Literature DB >> 11710947

Dominant lesional T cell receptor rearrangements persist in relapsing psoriasis but are absent from nonlesional skin: evidence for a stable antigen-specific pathogenic T cell response in psoriasis vulgaris.

S Vollmer1, A Menssen, J C Prinz.   

Abstract

In a previous study we reported that clonally expanded T cell receptor beta-chain rearrangements characterized the T cell receptor usage in skin lesions of psoriasis vulgaris and indicated antigen-specific T cell selection. To assess the relevance of clonal T cell expansion for disease progression, we now determined if select clonal T cell receptor rearrangements persisted over time and were present in nonlesional skin. Sequential biopsies were taken from psoriatic skin lesions of two patients. V-D-J junctional regions of T cell receptor beta-chain variable region gene families 2, 3, 6, 13S1, and BV17 were cloned and sequenced, as these particular BV gene families are preferentially selected in psoriatic skin lesions. The lesional T cell receptor rearrangements were compared with the T cell receptor usage in nonlesional skin and in blood. Several T cell receptor beta-chain rearrangements with high transcript frequency in the first lesional biopsy were again found in sequential lesional biopsies taken as much as 3 y later from psoriasis relapses. Only T cell receptor beta-chain rearrangements with low transcript abundance showed variability in that several clones appeared for the first time or disappeared. Although nonlesional skin also exhibited a restricted T cell receptor usage with clonal T cell receptor rearrangements, the T cell receptor usage in lesional and nonlesional skin differed nearly completely. The select lesional recurrence of identical T cell receptor rearrangements reveals that inflammation in psoriasis involves the same clonally expanded T cell populations and the same antigens over prolonged periods of time. It hereby suggests that specifically recruited and locally expanded T cell clones are permanently involved in psoriatic inflammation and may play a crucial part in disease perpetuation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710947     DOI: 10.1046/j.0022-202x.2001.01494.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  19 in total

Review 1.  Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

Authors:  Brian J Nickoloff; Frank O Nestle
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 2.  Animal models of psoriasis and psoriatic arthritis: an update.

Authors:  Curdin Conrad; Frank O Nestle
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 3.  Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis.

Authors:  J T Elder
Journal:  Genes Immun       Date:  2009-03-05       Impact factor: 2.676

4.  Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis.

Authors:  Stanley Cheuk; Maria Wikén; Lennart Blomqvist; Susanne Nylén; Toomas Talme; Mona Ståhle; Liv Eidsmo
Journal:  J Immunol       Date:  2014-03-07       Impact factor: 5.422

Review 5.  New insights of T cells in the pathogenesis of psoriasis.

Authors:  Yihua Cai; Chris Fleming; Jun Yan
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

Review 6.  Function and regulation of retinoic acid-inducible gene-I.

Authors:  Tomoh Matsumiya; Diana M Stafforini
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

7.  The molecular basis for peptide repertoire selection in the human leucocyte antigen (HLA) C*06:02 molecule.

Authors:  Jesse I Mobbs; Patricia T Illing; Nadine L Dudek; Andrew G Brooks; Daniel G Baker; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian
Journal:  J Biol Chem       Date:  2017-08-30       Impact factor: 5.157

Review 8.  Immunopathogenic mechanisms in psoriasis.

Authors:  J E Gudjonsson; A Johnston; H Sigmundsdottir; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

Review 9.  Psoriasis.

Authors:  Paola Di Meglio; Federica Villanova; Frank O Nestle
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-01       Impact factor: 6.915

Review 10.  A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses.

Authors:  Kamran Ghoreschi; Ulrich Mrowietz; Martin Röcken
Journal:  J Mol Med (Berl)       Date:  2003-07-18       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.